Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-001236-21Phase 4Completed
Phase 4, open-label trial of mercaptopurine in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Kjeld Schmiegelow. Primary endpoint: Tmax. Started May 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-001236-21.